top of page
acrichards90

New Jersey pushes for decriminalization. Psilocybin studied as anti-depressant replacement.

Jenny Kane/AP

 


In recent years, there has been a growing interest in exploring the medical applications of psychedelics, particularly mushrooms, for conditions such as anxiety and depression. A bill introduced in New Jersey, known as the “Psilocybin Behavioral Health Access and Services Act,” aims to decriminalize the use of psilocybin, the active compound in magic mushrooms, for therapeutic purposes.

 

 

Dr. Jeremy Teissere, a distinguished professor of neuroscience at Muhlenberg College, emphasizes the need for careful consideration before integrating psychedelics into medical practice. While there is promising data indicating the efficacy of psilocybin in reducing anxiety and addressing trauma-related mood changes, there are significant questions surrounding its regulation and administration.

 

One of the key concerns is determining the appropriate setting for administering psilocybin. Should it be available for home use with a prescription, or should it only be administered in a clinical setting? Teissere stresses that these decisions must be informed by robust clinical standards, which are currently lacking due to the limited long-term studies on the subject.

 

Comparing psilocybin to conventional antidepressants like SSRIs (selective serotonin reuptake inhibitors), Teissere notes that psilocybin appears to offer similar benefits without some of the common negative side effects associated with SSRIs, such as sexual dysfunction and weight gain. Additionally, microdosing—taking tiny amounts of psilocybin—has shown promise in reducing anxiety without inducing psychedelic effects.

 

Despite the speculation that the legalization of medical marijuana could pave the way for other drugs like magic mushrooms, Teissere warns against hastiness. While there are ongoing studies in states like Oregon, where psilocybin has been legalized, he emphasizes the need for caution and professional supervision when using psychedelics, both medically and recreationally.

 

In conclusion, while the potential therapeutic benefits of magic mushrooms are intriguing, it is essential to proceed with caution, ensuring that rigorous standards are in place to mitigate potential risks and maximize therapeutic outcomes.

 

 

Sources: Brittany Sweeney, “Are magic mushrooms the new antidepressant? As studies look at legalization, some experts urge caution”, LehighValleyNews.com, 03/26/2024, https://www.lehighvalleynews.com/health-news/are-magic-mushrooms-the-new-antidepressant-as-studies-look-at-legalization-some-experts-urge-caution, Accessed  03/26/24.

10 views0 comments

Comments


bottom of page